GGrantIndex
Sort

78,016 grants matching breast cancer

PDX Core

$483,808
Bingliang Fang · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA

F18 EF5 PET/CT IMAGING IN PATIENTS WITH BRAIN METASTASES FROM BREAST CANCER

$483,772
Trustees Of The University Of Pennsylvania, The · · FY2011 · Department of Defense

Project 2: Combined CAR-T cell therapy

$483,710
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA

Optimized ultrasound-enhanced immunotherapy

$483,694
Katherine W Ferrara · Stanford University · R01 · FY2019 · CA

Colon cancer disparity elimination: a faith-based participatory partnership

$483,685
John R. Ureda · South Carolina Hiv Council · R24 · FY2011 · MD

Preclinical characterization of EMT/CSC-specific small molecule inhibitors for TNBCs

$483,655
Sendurai Ayyavoo Mani · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Intraoperative Label-Free Optical Molecular Imaging of Breast Tumor Margins

$483,605
Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2014 · CA

Normal and Cancer Stem Cells of the Mammary Gland

$483,604
Jonathan A. Cooper · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Evidence-based Dissemination for Mammography Adherence in Safety Net Communities

$483,604
Linda D Highfield · University Of Texas Hlth Sci Ctr Houston · R18 · FY2014 · HS

Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-Operative Treatment Trials

$483,603
Nola M. Hylton · University Of California, San Francisco · R01 · FY2018 · CA

Nitric Oxide as a Modifier of Oxidative Stress

$483,577
David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA

Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy

$483,568
Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy

$483,558
George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA

Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy

$483,558
George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · CA

Role of ACER2 in cancer chemoresistance and metastasis

$483,556
Cungui Mao · State University New York Stony Brook · R01 · FY2024 · CA

Health Outcomes and Dioxin Exposure of Women and Children in Seveso

$483,553
Brenda Eskenazi · University Of California Berkeley · R01 · FY2010 · ES

Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain

$483,488
Cyrus M Ghajar · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

Membrane-based immunotherapy for triple negative breast cancer- a partnered approach

$483,484
Periasamy Selvaraj · Emory University · R01 · FY2018 · CA

Integrating Mammograms in Analyses of Genes and Environment in Sisters (IMAGES)

$483,454
Parisa Tehranifar · Columbia University Health Sciences · U01 · FY2018 · CA

Effects of Tibetan Yoga on Fatigue and Sleep in Cancer

$483,440
Lorenzo Cohen · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA

Describing and Understanding Racial Disparities

$483,417
Jeffrey H Silber · Children'S Hosp Of Philadelphia · R01 · FY2011 · HS

In situ Redirection of T cell Specificity and Imaging of Targeted CAR Expression.

$483,404
Zelig Eshhar · Tel-Aviv Sourasky Medical Center · R01 · FY2016 · EB

Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer

$483,395
Joseph Nicholas Bodor · Research Inst Of Fox Chase Can Ctr · R21 · FY2024 · CA

Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis

$483,382
Amit Singal · Ut Southwestern Medical Center · R01 · FY2019 · CA

GREENVILLE, SOUTH CAROLINA CCOP

$483,362
Oncology &Hematology Associates Of Sc · U10 · FY2000 · CA